Helping prevent haemorrhagic stroke with The Natalie Kate Moss Trust
The Natalie Kate Moss Trust (NKMT) was set up in 2012 by the Moss family, following the sudden death of Natalie at the age of 26 after an unexpected brain haemorrhage.Focusing on turning this tragedy into something positive, their mission is to empower more people to...
brainHealth Manchester joins the £4.5m Blood Biomarker Challenge to Accelerate Alzheimer’s Research
Dementia theme lead Dr Ross Dunne will be overseeing the research team at the Dementia Research Centre and the brainHealth Manchester clinic in the Dementias Platform UK (DPUK) blood biomarker challenge, a project which aims to bring cutting-edge blood tests for diagnosing dementia within the NHS.
Novel study aims to shed new light on vision problems after stroke
An exciting new study is underway working with patients to develop treatments for post-stroke vision impairment. The results will be used for future training to help improve the visual field area after stroke and other brain injuries.
Podcast: Understanding NF2
NF2-Related Schwannomatosis is a rare genetic condition affecting 1 in 33,000, marked by noncancerous tumours in the nervous system. Despite its impact, it remains lesser-known. Our latest podcast episode shines a light on NF2, making the complex understandable.
North American Skull Base Society meeting
The North American Skull Base Society meeting took place in Atlanta from 16-18 February. It was a fantastic forum for learning & discussion across the whole breadth of skull base surgery. Colleagues from the Jeff attended to give invited talks at the meeting.
Inaugural Jeff Showcase
Our inaugural showcase went ahead on Friday 19 January at The Hyatt Regency Manchester, the event was attended by over 150 delegates including academics, clinicians, students, people from industry, charities, and members of the public.
MRC Project Grant awarded to Dr. R. Wykes for evaluating stroke impact through graphene-enabled nanotechnology
The team aims to bring this cutting-edge technology to preclinical stroke research to gain a better understanding of the mechanisms of SD initiation and their involvement in worsening stroke severity. This work will be a crucial first step in the maturity of this technology towards future clinical translation where they anticipate that it will greatly facilitate management of patients in the neuro-intensive care units.
CHOSEN trial results paves the way for a nationwide phase 3 trial
Pneumonia affects around 1 in 12 people after a stroke and increases their chances of death and disability. CHOSEN aimed to determine the feasibility of different oral healthcare treatments, supported by staff education and training, to prevent pneumonia in UK stroke unit care.
Sir Geoffrey Jefferson talk at SBNS 2023
Watch American neurosurgeon Dr Russell J Andrews present a special talk on Professor Sir Geoffrey Jefferson at the 2023 Society of British Neurological Surgeons (SBNS) conference.
Study aims to help preserve hearing in people with vestibular schwannomas
A team of researchers from our centre have started a new pilot study looking at hearing tests for people with vestibular schwannomas (VS).
Address
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Connect with us
Recent Comments